Skip Navigation

A phase I/II trial of Rucaparib in combination with Ramucirumab with or without Nivolumab in previously treated patients with advanced gastric and esophageal adenocarcinoma RiME

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03995017

Study #:
STUDY00144207

Start Date:
Jan 08, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03995017

View Complete Trial Details & Eligibility at ClinicalTrials.gov